公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2013 | Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; HUNG-BIN TSAI ; MENG-KUN TSAI ; Chen, Shih-I; JOU-WEI LIN ; Yang, Sheng-Shun; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; Yu, Ming-Lung; JIA-HORNG KAO | Annals of internal medicine | 85 | 77 | |
2006 | Pegylated interferons for the treatment of chronic hepatitis B. | CHUN-JEN LIU ; JIA-HORNG KAO | Recent patents on anti-infective drug discovery | 5 | 0 | |
2005 | Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: A prospective study | GUAN-TARN HUANG ; PO-HUANG LEE ; Tsang Y.-M.; Lai M.-Y.; PEI-MING YANG ; REY-HENG HU ; PEI-JER CHEN ; JIA-HORNG KAO ; JIN-CHUAN SHEU ; Lee, Cha-Ze ; DING-SHINN CHEN | Annals of Surgery | 177 | 163 | |
2020 | Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing | Yang Y.-C.; Chen Y.-H; JIA-HORNG KAO ; Ching C; Liu I.-J; Wang C.-C; Tsai C.-H; Wu F.-Y; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; HUNG-CHIH YANG | Molecular Therapy - Nucleic Acids | 59 | 52 | |
2014 | Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: Molecular mechanisms and clinical significance | HUNG-CHIH YANG ; JIA-HORNG KAO | Emerging Microbes and Infections | 102 | 104 | |
2012 | Persistent hepatitis B viral replication in a FVB/N mouse model: Impact of host and viral factors | Chen S.-H.; Wu H.-L.; JIA-HORNG KAO ; Hwang L.-H. | PLoS ONE | 32 | 16 | |
2015 | Perspectives and control of hepatitis B virus infection in Taiwan | Lin C.-L.; JIA-HORNG KAO | Journal of the Formosan Medical Association | 64 | 62 | |
2016 | Perspectives on dual hepatitis B and C infection in Taiwan | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; TAI-CHUNG TSENG ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 13 | 12 | |
2016 | A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection | JIA-HORNG KAO ; Chien R.-N.; Chang T.-T.; Peng C.-Y.; Hu T.-H.; Lo G.-H.; Wang H.-Y.; Chen J.-J.; Yang J.C.; Knox S.J.; Han L.; Mo H.; Mathias A.; Brainard D.M.; Sheen I.-S.; Hsu Y.-C.; Chu C.-J.; Chuang W.-L. | Liver International | 25 | 25 | |
2018 | Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B | Hsu C.-W.; Su W.-W.; Lee C.-M.; Peng C.-Y.; Chuang W.-L.; JIA-HORNG KAO ; Chu H.-C.; Huang Y.-H.; Chien R.-N.; Liaw Y.-F. | Journal of the Formosan Medical Association | 20 | 17 | |
1996 | Phylogenetic analysis of GB virus C: Comparison of isolates from Africa, North America, and Taiwan | JIA-HORNG KAO ; PEI-JER CHEN ; Hsiang S.-C.; Chen W.; DING-SHINN CHEN | Journal of Infectious Diseases | 51 | 52 | |
2014 | A pilot study of add-on oral hypoglycemic agents in treatment-naïve genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin | Hsu C.-S.; SHIH-JER HSU ; Lin H.H.; TAI-CHUNG TSENG ; Wang C.-C.; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 8 | 7 | |
2014 | Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: A prospective study in Taiwan | CHI-LING CHEN ; WEI-SHIUNG YANG ; Yang H.-I.; Chen C.-F.; You S.-L.; Wang L.-Y.; Lu S.-N.; CHUN-JEN LIU ; JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN ; Chen C.-J. | Cancer Epidemiology Biomarkers and Prevention | 19 | 16 | |
2022 | Pooling data to assess risks and benefits of discontinuing nucleos(t)ide analogs in patients with chronic hepatitis B: challenges and opportunities | Hsu, Yao-Chun; Tseng, Cheng-Hao; TUNG-HUNG SU ; JIA-HORNG KAO ; Nguyen, Mindie H | Gut | 3 | 2 | |
1997 | Positive and negative strand of hepatitis C virus RNA sequences in peripheral blood mononuclear cells in patients with chronic hepatitis C: No correlation with viral genotypes 1b, 2a, and 2b | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; Wang T.-H.; DING-SHINN CHEN | Journal of Medical Virology | 45 | | |
1994 | Possible role of high-titer maternal viremia in perinatal transmission of hepatitis c virus | HO-HSIUNG LIN ; JIA-HORNG KAO ; HONG-YUAN HSU ; YEN-HSUAN NI ; Shiou-Hwei Yeh ; Hwang L.-H.; MEI-HWEI CHANG ; Hwang S.-C.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Infectious Diseases | 180 | 140 | |
2001 | Post-partum acute exacerbation of chronic hepatitis in a hepatitis C-carrier mother | Chen J.-D.; Chung J.-L.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 13 | 12 | |
2023 | Pre-operative gamma-glutamyl transferase levels predict outcomes in hepatitis B-related hepatocellular carcinoma after curative resection | TUNG-HUNG SU ; SHANG-CHIN HUANG ; CHI-LING CHEN ; SHIH-JER HSU ; SIH-HAN LIAO ; CHUN-MING HONG ; TAI-CHUNG TSENG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; YAO-MING WU ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | 2 | 0 | |
2006 | Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinoma | Tong M.J.; Blatt L.M.; JIA-HORNG KAO ; Cheng J.T.; Corey W.G. | World Journal of Gastroenterology | 60 | 53 | |
2004 | Precore/Core Promoter Mutations and Genotypes of Hepatitis B Virus in Chronic Hepatitis B Patients with Fulminant or Subfulminant Hepatitis | CHUN-JEN LIU ; JIA-HORNG KAO ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Medical Virology | 39 | 37 | |